BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2390493)

  • 1. Etretinate and the risk for teratogenicity: drug monitoring in a pregnant woman for 9 months after stopping treatment.
    Vahlquist A; Rollman O
    Br J Dermatol; 1990 Jul; 123(1):131. PubMed ID: 2390493
    [No Abstract]   [Full Text] [Related]  

  • 2. [Teratogenic effects of etretinate in humans].
    Happle R; Traupe H; Bounameaux Y; Fisch T
    Dtsch Med Wochenschr; 1984 Sep; 109(39):1476-80. PubMed ID: 6479047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprophylaxis of malaria.
    Harrison HC
    Med J Aust; 1986 Nov; 145(10):551. PubMed ID: 3773820
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of hydroxychloroquine in lupus pregnancy: the British experience.
    Khamashta MA; Buchanan NM; Hughes GR
    Lupus; 1996 Jun; 5 Suppl 1():S65-6. PubMed ID: 8803914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of cutaneous lupus erythematosus with etretinate.
    Ruzicka T; Meurer M; Braun-Falco O
    Acta Derm Venereol; 1985; 65(4):324-9. PubMed ID: 2413687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Embryonal malformation following etretinate therapy of Darier's disease in the mother].
    Kietzmann H; Schwarze I; Grote W; Ravens U; Jänig U; Harms D
    Dtsch Med Wochenschr; 1986 Jan; 111(2):60-2. PubMed ID: 3940838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pregnancy and antiepileptic agents; the value of prenatal ultrasonography studies for the detection of congenital malformations].
    Wladimiroff JW; Stewart PA; Reuss A; van Swaay E; Lindhout D; Sachs ES
    Ned Tijdschr Geneeskd; 1988 Aug; 132(32):1486-9. PubMed ID: 3050548
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases.
    Buchanan NM; Toubi E; Khamashta MA; Lima F; Kerslake S; Hughes GR
    Ann Rheum Dis; 1996 Jul; 55(7):486-8. PubMed ID: 8774170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prenatal diagnosis following teratogenic effects].
    Tews G; Arzt W; Hintermüller P
    Gynakol Rundsch; 1989; 29 Suppl 2():283-7. PubMed ID: 2693248
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of commonly used antipsychotics (typical and atypical) in pregnancy and lactation.
    Iqbal MM; Kunwar A; Lee K; Khan S; Megna J; Iqbal MD; Fremont W
    J La State Med Soc; 2005; 157(2):94-7. PubMed ID: 16022275
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prenatal diagnosis in pregnant women with the toxic oil syndrome].
    Ramos C; Ayuso C; Palacios S; Bello MJ; Rey JA; Valcárcel E; Martínez P; Sánchez Cascos A
    Rev Clin Esp; 1983 May; 169(3):161-3. PubMed ID: 6612028
    [No Abstract]   [Full Text] [Related]  

  • 12. Malformation of fetus conceived 4 months after termination of maternal etretinate treatment.
    Grote W; Harms D; Jänig U; Kietzmann H; Ravens U; Schwarze I
    Lancet; 1985 Jun; 1(8440):1276. PubMed ID: 2860474
    [No Abstract]   [Full Text] [Related]  

  • 13. Prescribing in pregnancy. Identifying abnormalities.
    Whittle MJ; Hanretty KP
    Br Med J (Clin Res Ed); 1986 Dec; 293(6560):1485-8. PubMed ID: 3099923
    [No Abstract]   [Full Text] [Related]  

  • 14. Mepacrine and pregnancy.
    Humphreys F; Marks JM
    Br J Dermatol; 1988 Mar; 118(3):452. PubMed ID: 3355788
    [No Abstract]   [Full Text] [Related]  

  • 15. Teratogenicity of isotretinoin and etretinate.
    Hopf G; Mathias B
    Lancet; 1988 Nov; 2(8620):1143. PubMed ID: 2903358
    [No Abstract]   [Full Text] [Related]  

  • 16. Intractable skin disorders treated with the aromatic retinoid etretinate.
    Presbury DG
    S Afr Med J; 1984 Mar; 65(13):501-2. PubMed ID: 6369566
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased congenital heart defects in children born to women with systemic lupus erythematosus: results from the offspring of Systemic Lupus Erythematosus Mothers Registry Study.
    Vinet É; Pineau CA; Scott S; Clarke AE; Platt RW; Bernatsky S
    Circulation; 2015 Jan; 131(2):149-56. PubMed ID: 25355915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teratogenic risk with etretinate and acitretin treatment.
    Geiger JM; Baudin M; Saurat JH
    Dermatology; 1994; 189(2):109-16. PubMed ID: 8075435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: Absence of chloroquine-induced ototoxicity in a fetus.
    Ross JB; Garatsos S
    Arch Dermatol; 1974 Apr; 109(4):573. PubMed ID: 4819124
    [No Abstract]   [Full Text] [Related]  

  • 20. Antenatal diagnosis for the clinician.
    Bombard AT
    J Miss State Med Assoc; 1988 Oct; 29(10):307-11. PubMed ID: 3230584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.